Moneycontrol PRO
HomeNewsAshish chaturmohta of fortune group

Ashish Chaturmohta Of Fortune Group

Jump to
  • Buy ICICI Bank, Strides Arcolab, BHEL: Ashish Chaturmohta

    Ashish Chaturmohta of Fortune Group recommends buying ICICI Bank, Strides Arcolab and BHEL.

  • BHEL may cross Rs 290: Ashish Chaturmohta

    BHEL may cross Rs 290: Ashish Chaturmohta

    Ashish Chaturmohta of Fortune Group is of the view that Bharat Heavy Electricals may cross Rs 290.

  • Maruti Suzuki may hit Rs 4400-4450, says Ashish Chaturmohta

    Maruti Suzuki may hit Rs 4400-4450, says Ashish Chaturmohta

    Ashish Chaturmohta of Fortune Group is of the view that Maruti Suzuki may hit Rs 4400-4450.

  • Go long in Aditya Birla Nuvo, says Ashish Chaturmohta

    Go long in Aditya Birla Nuvo, says Ashish Chaturmohta

    Ashish Chaturmohta of Fortune Group recommends going long in Aditya Birla Nuvo for a target of Rs 2000.

  • Go long in Canara Bank, advises Ashish Chaturmohta

    Go long in Canara Bank, advises Ashish Chaturmohta

    Ashish Chaturmohta of Fortune Group recommends going long in Canara Bank with a target of Rs 315 in next two to three trading sessions.

  • Go long in Strides Arcolab: Ashish Chaturmohta

    Go long in Strides Arcolab: Ashish Chaturmohta

    Ashish Chaturmohta of Fortune Group is of the view that one cango long in Strides Arcolab as the stock may test Rs 1,360-1,370 in next two to three weeks.

  • Buy HDFC, SKS Micro, Dr Reddy's, Lupin: Ashish Chaturmohta

    Buy HDFC, SKS Micro, Dr Reddy's, Lupin: Ashish Chaturmohta

    Ashish Chaturmohta of Fortune Group recommends buying HDFC, SKS Microfinance, Dr Reddy's Labs and Lupin.

  • Buy Coal India for long term, advises Ashish Chaturmohta

    Buy Coal India for long term, advises Ashish Chaturmohta

    Ashish Chaturmohta of Fortune Group recommends going long in Coal India for upside target of Rs 450.

  • Go long in Dr Reddy's Labs, target Rs 3700: Chaturmohta

    Go long in Dr Reddy's Labs, target Rs 3700: Chaturmohta

    Ashish Chaturmohta of Fortune Group recommends going long in Dr Reddy's Laboratories for a target of Rs 3700.

  • Go long in SKS Microfinance, advises Ashish Chaturmohta

    Go long in SKS Microfinance, advises Ashish Chaturmohta

    Ashish Chaturmohta of Fortune Group recommends going long in SKS Microfinance for a target of Rs 520 in next three-five trading sessions.

  • Strides Arcolab may hit Rs 1220: Ashish Chaturmohta

    Strides Arcolab may hit Rs 1220: Ashish Chaturmohta

    Ashish Chaturmohta of Fortune Group is of the view that Strides Arcolab may hit Rs 1220.

  • Short M&M Financial Services: Ashish Chaturmohta

    Short M&M Financial Services: Ashish Chaturmohta

    Ashish Chaturmohta of Fortune Group recommends shorting Mahindra & Mahindra Financial Services as the stock may crack Rs 230-232 in next 2-3 trading sessions.

  • Buy Bharti Airtel, may cross Rs 440-445: Ashish Chaturmohta

    Buy Bharti Airtel, may cross Rs 440-445: Ashish Chaturmohta

    Ashish Chaturmohta of Fortune Group recommends buying Bharti Airtel as the stock may cross Rs 440-445.

  • Aurobindo Pharma may test Rs 1400, says Ashish Chaturmohta

    Aurobindo Pharma may test Rs 1400, says Ashish Chaturmohta

    Ashish Chaturmohta of Fortune Group is of the view that Aurobindo Pharma may test Rs 1400.

  • ICICI Bank may test Rs 330-350 in 6-9 months: Chaturmohta

    ICICI Bank may test Rs 330-350 in 6-9 months: Chaturmohta

    Ashish Chaturmohta of Fortune Group is of the view that with a view of six to nine months, one may see ICICI Bank move to Rs 330-350.

  • Hold Hindustan Petroleum Corporation: Ashish Chaturmohta

    Hold Hindustan Petroleum Corporation: Ashish Chaturmohta

    Ashish Chaturmohta of Fortune Group recommends holding Hindustan Petroleum Corporation as the stock may test Rs 820.

  • Short IDBI Bank, advises Ashish Chaturmohta

    Short IDBI Bank, advises Ashish Chaturmohta

    Ashish Chaturmohta of Fortune Group is of the view that one may short IDBI Bank as the stock may test Rs 60.

  • Aurobindo Pharma may test Rs 1430-1440: Ashish Chaturmohta

    Aurobindo Pharma may test Rs 1430-1440: Ashish Chaturmohta

    Ashish Chaturmohta of Fortune Group is of the view that Aurobindo Pharma may test Rs 1,430-1,440 in next couple of trading sessions.

  • Short Just Dial, advises Ashish Chaturmohta

    Short Just Dial, advises Ashish Chaturmohta

    Ashish Chaturmohta of Fortune Group recommends shorting Just Dial for a downside target of Rs 1000.

  • YES Bank may hit Rs 880-900, says Ashish Chaturmohta

    YES Bank may hit Rs 880-900, says Ashish Chaturmohta

    Ashish Chaturmohta of Fortune Group is of the view that YES Bank may hit Rs 880-900.

  • Buy AB Nuvo, Adani Enterprises; sell BOI: Chaturmohta

    Buy AB Nuvo, Adani Enterprises; sell BOI: Chaturmohta

    Ashish Chaturmohta of Fortune Group recommends buying Aditya Birla Nuvo and Adani Enterprises and advises selling Bank of India.

  • Short Reliance Capital, target Rs 375-380: Chaturmohta

    Short Reliance Capital, target Rs 375-380: Chaturmohta

    Ashish Chaturmohta of Fortune Group is of the view that one may short Reliance Capital with a target of Rs 375-380.

  • Go long in Kotak Mahindra Bank: Ashish Chaturmohta

    Go long in Kotak Mahindra Bank: Ashish Chaturmohta

    Ashish Chaturmohta of Fortune Group recommends going long in Kotak Mahindra Bank with a target of Rs 1440 and feels that Bank of Baroda may test Rs 154-155.

  • Short Reliance Infrastructure, advises Ashish Chaturmohta

    Short Reliance Infrastructure, advises Ashish Chaturmohta

    Ashish Chaturmohta of Fortune Group recommends shorting Reliance Infrastructure with a target of Rs 380-385.

  • Go long in YES Bank, SKS Microfinance: Ashish Chaturmohta

    Go long in YES Bank, SKS Microfinance: Ashish Chaturmohta

    Ashish Chaturmohta of Fortune Group recommends going long in YES Bank, SKS Microfinance and Indiabulls Housing Finance.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347